0.54 EUR
5.70 M EUR
59.39 M EUR
1.42 M
About SHEDIR PHARMA GROUP
Sector
CEO
Antonio Scala
Headquarters
Piano di Sorrento
Website
Founded
2014
ISIN
IT0005379620
FIGI
BBG00PNYV7M0
Shedir Pharma Group SpA is a holding company, which engages in the research and development of nutraceuticals and medical devices. It operates through the BU1 and BU2 business units. The BU1 unit focuses on the development, formulation, promotion, and marketing of nutraceuticals, dermocosmetics, and medical equipment. The BU2 unit specializes in the production and distribution of medicines and other pharmaceuticals. The company was founded by Umberto di Maio on October 13, 2014 and is headquartered in Piano di Sorrento, Italy.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SHE is 4.86 EUR — it hasn't changed in the past 24 hours. Watch SHEDIR PHARMA GROUP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange SHEDIR PHARMA GROUP stocks are traded under the ticker SHE.
SHE stock hasn't changed in a week, the last month showed zero change in price, over the last year SHEDIR PHARMA GROUP has showed a 8.97% increase.
We've gathered analysts' opinions on SHEDIR PHARMA GROUP future price: according to them, SHE price has a max estimate of 7.98 EUR and a min estimate of 7.98 EUR. Watch SHE chart and read a more detailed SHEDIR PHARMA GROUP stock forecast: see what analysts think of SHEDIR PHARMA GROUP and suggest that you do with its stocks.
SHE stock is 0.00% volatile and has beta coefficient of −0.14. Track SHEDIR PHARMA GROUP stock price on the chart and check out the list of the most volatile stocks — is SHEDIR PHARMA GROUP there?
Yes, you can track SHEDIR PHARMA GROUP financials in yearly and quarterly reports right on TradingView.
SHE net income for the last half-year is 1.56 M EUR, while the previous report showed 4.52 M EUR of net income which accounts for −65.55% change. Track more SHEDIR PHARMA GROUP financial stats to get the full picture.
SHEDIR PHARMA GROUP dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 4.69% and 33.75% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHEDIR PHARMA GROUP EBITDA is 12.61 M EUR, and current EBITDA margin is 20.62%. See more stats in SHEDIR PHARMA GROUP financial statements.
Like other stocks, SHE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHEDIR PHARMA GROUP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHEDIR PHARMA GROUP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHEDIR PHARMA GROUP stock shows the strong buy signal. See more of SHEDIR PHARMA GROUP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.